We strive to deliver personalized care to our patients by taking into account not only their specific type of cancer but their desires and goals as well. Our research programs work toward developing novel treatments that harness and enhance the immune system’s ability to detect and kill cancer cells. Natural killer cells are a type of immune cell capable of eliminating cancer cells. Much of the research we do focuses on augmenting or recovering the function of these cells.
I’ve published 87 peer-reviewed clinical, translational and laboratory based research papers in journals such as Journal of Clinical Oncology, Blood, PNAS, Cancer Cell, Clinical Cancer Research and many others. My team’s work has been presented at international scientific meetings around the world, and has
been funded by the National Cancer Institute, the American Cancer Society, Pelotonia and other sources.
I feel blessed to work at The James because of my team. I believe that the collective care we provide to patients is much greater than our individual contributions. Our patients have the added benefit of the entire institution supporting them in their fight to overcome cancer.
Northeastern Ohio Universities College of Medicine
University of Virginia Health System
7/1/2000 - 6/30/2003
Specialties and conditions I treat
- Bone Marrow Transplantation
- Multiple Myeloma
- Blood Cancers
Locations where I practice
More about my work
Ohio State University Wexner Medical Ctr
7/1/2003 - 6/30/2006
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
- Psychosocial Factors Associated With High Readmission Rates Longer Hospital Stays
- MEDIA ADVISORY -- Ohio State Cancer Experts Available To Provide Perspective On Research Presented At Annual ASCO Meeting
- Local Group Raises Money For Multiple Myeloma Research
- Pelotonia Idea Grants To Fund Ohio State Cancer Research
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Benson has reported no financial relationships with medical device, research and/or drug companies.